Inibio's Botulinum Toxin Inibo Secures NMPA Approval: What This Means for the Chinese Market in 2027
AI 요약 정보
- Inibio's Inibo wins China's NMPA approval
- Inibio targets China launch in Q1 2027
- Inibo is China's ninth approved toxin, third from South Korea
